Related Experiment Video
Updated: Nov 19, 2025

Porcine Corneal Tissue Explant to Study the Efficacy of Herpes Simplex Virus-1 Antivirals
Published on: September 20, 2021
[Herpes Simplex Virus Infection in Two Premature Infants - Diagnostic and Therapeutic Management]
Roland Haase1,2, Gregor Seliger3, Jan Baier1
1Abteilung für Neonatologie und Pädiatrische Intensivmedizin, Universitätsklinikum Halle (Saale), Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Deutschland.
Insights
Neonatal herpes simplex virus (HSV) infections pose significant risks, particularly for premature infants. Early diagnosis and treatment with acyclovir are crucial for managing these severe systemic infections.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Virology
Background:
- Neonatal herpes simplex virus (HSV) infections are rare but severe, carrying high morbidity and mortality rates, especially when treatment is delayed.
- Premature infants are especially vulnerable due to immature immune systems.
- Symptoms of neonatal HSV can mimic other serious conditions like sepsis, complicating diagnosis.
Purpose of the Study:
- To present two cases of premature infants with systemic HSV infections.
- To discuss the diagnostic and therapeutic management strategies for neonatal HSV.
- To highlight the importance of timely intervention in improving outcomes.
Main Methods:
- Case report of two premature infants diagnosed with systemic HSV infections.
- Review of diagnostic approaches, including patient history and specific tests.
- Description of treatment protocols involving intravenous and enteral acyclovir.
Main Results:
- Both infants presented with systemic HSV infections.
- Successful treatment was achieved using intravenous acyclovir followed by suppressive enteral therapy.
- The cases underscore the need for prompt diagnosis and management.
Conclusions:
- Systemic HSV infections in premature neonates require vigilant diagnosis and prompt treatment.
- Intravenous and subsequent enteral acyclovir therapy is an effective management strategy.
- Early intervention is critical to mitigate the high risks associated with neonatal HSV.
Abstract:
Herpes simplex virus type 1 or 2 (HSV 1/2)-related infections in neonates are rare but associated with high morbidity and mortality, especially if specific treatment is delayed. Due to immaturity of the immunological system, premature infants are particularly at risk. In addition, symptoms of neonatal HSV infections may imitate prematurity-related problems, such as sepsis. So, a thorough patient's history and appropriate diagnostic measures are important to confirm the diagnosis. We present 2 premature infants with systemic HSV infections and discuss diagnostic and therapeutic management. Both were treated with intravenous acyclovir followed by enteral aciclovir suppressive therapy.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection IV: Nursing Management
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Tonsillitis II: Management
Myocarditis III: Medical Management

